Colgate-Palmolive (NYSE:CL) Holdings Decreased by Forte Capital LLC ADV

Forte Capital LLC ADV lessened its stake in Colgate-Palmolive (NYSE:CL) by 2.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,531 shares of the company’s stock after selling 498 shares during the period. Forte Capital LLC ADV’s holdings in Colgate-Palmolive were worth $1,477,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. OFI Invest Asset Management acquired a new position in Colgate-Palmolive during the third quarter worth about $25,000. Avion Wealth lifted its position in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. acquired a new position in Colgate-Palmolive in the 4th quarter worth approximately $34,000. Kayne Anderson Rudnick Investment Management LLC grew its position in Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares in the last quarter. Finally, West Branch Capital LLC raised its stake in Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of a number of research analyst reports. Bank of America lifted their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. UBS Group increased their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Barclays boosted their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, April 30th. Finally, StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $91.44.

Colgate-Palmolive Price Performance

Shares of CL stock traded down $0.03 during mid-day trading on Friday, reaching $92.88. The company’s stock had a trading volume of 5,432,695 shares, compared to its average volume of 4,878,342. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.28 and a current ratio of 1.06. The firm’s 50-day moving average is $88.35 and its two-hundred day moving average is $82.21. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $93.25. The company has a market cap of $76.20 billion, a P/E ratio of 29.39, a PEG ratio of 3.43 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter last year, the company earned $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. On average, research analysts predict that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the transaction, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Over the last three months, insiders sold 159,048 shares of company stock valued at $13,336,846. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.